The risk stratification based on the CHA₂DS₂-VASc may predict the response to intravenous thrombolysis after stroke

Manuel Cappellari1, Paolo Bovi, Nicola Micheletti

  • 1Stroke Unit, Division of Neurology, Department of Neuroscience, Azienda Ospedaliera Univarsitaria Integrata, Piazzale A. Stefani 1, 37126, Verona, Italy, manuel_cappellari@libero.it.

Journal of Neurology
|August 15, 2013
PubMed

Insights

The CHA2DS2-VASc score predicts response to intravenous thrombolysis in stroke patients. Low-risk patients benefit most, while very high-risk patients show a failed response to this treatment.

Area of Science:

  • Neurology
  • Cardiology
  • Emergency Medicine

Background:

  • The CHA2DS2-VASc score is established for assessing thromboembolic risk in patients with atrial fibrillation (AF).
  • Its utility in predicting treatment response to intravenous thrombolysis in acute stroke is less understood.
  • Understanding risk stratification may optimize thrombolytic therapy selection and outcomes.

Purpose of the Study:

  • To evaluate if prestroke CHA2DS2-VASc score stratification predicts patient response to intravenous (IV) thrombolysis.
  • To determine if baseline risk influences outcomes like major improvement or functional status post-thrombolysis.

Main Methods:

  • Analysis of prospectively collected data from 516 AF and non-AF stroke patients treated with IV thrombolysis.
  • Outcomes assessed at 24 hours (NIHSS score) and 3 months (mRS score).
  • Multivariate analysis used to compare outcomes across different CHA2DS2-VASc risk categories.

Main Results:

  • Lower odds of major improvement and excellent outcomes were observed in patients with intermediate (CHA2DS2-VASc=1), moderately high (CHA2DS2-VASc=2), and very high (CHA2DS2-VASc>3) risk scores compared to low-risk (CHA2DS2-VASc=0).
  • Higher odds of deterioration or unfavorable outcomes were seen only in the very high-risk group.
  • A low-risk CHA2DS2-VASc score predicted an effective response to IV thrombolysis.

Conclusions:

  • Prestroke CHA2DS2-VASc score is a significant predictor of IV thrombolysis response in stroke patients.
  • Low-risk patients are more likely to respond effectively, whereas very high-risk patients have a higher likelihood of failed response.
  • Risk stratification using CHA2DS2-VASc may aid in personalizing thrombolytic treatment decisions for stroke patients.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...